The appearance of FRβ in TAMs suggested that FRβ may be a useful breast cancer marker and a potential target for anti-cancer therapy, in addition to FRα, because breast cancer development and progression are highly dependent on specialized tumor-associated stroma7, as tumors rarely develop in the absence of this microenvironment. This evidence concerns the gene FOLR2 and breast carcinoma.